Myron Holubiak
2022
In 2022, Myron Holubiak earned a total compensation of $1.2M as Executive Vice Chairman at Citius Pharmaceuticals, a 26% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $170,000 |
|---|---|
| Option Awards | $620,056 |
| Salary | $450,000 |
| Total | $1,240,056 |
Holubiak received $620.1K in option awards, accounting for 50% of the total pay in 2022.
Holubiak also received $170K in non-equity incentive plan and $450K in salary.
Rankings
In 2022, Myron Holubiak's compensation ranked 2,617th out of 5,760 executives tracked by ExecPay. In other words, Holubiak earned more than 54.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,617 out of 5,760 | 55th |
Division Manufacturing | 1,454 out of 3,136 | 54th |
Major group Chemicals And Allied Products | 661 out of 1,422 | 54th |
Industry group Drugs | 614 out of 1,323 | 54th |
Industry Pharmaceutical Preparations | 441 out of 969 | 55th |
Source: SEC filing on December 22, 2022.
Holubiak's colleagues
We found three more compensation records of executives who worked with Myron Holubiak at Citius Pharmaceuticals in 2022.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018